bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.11.24.689918

Piperine activates the thick filament of resting rat skeletal muscle, enhancing dynamic contractility in a fiber-type-dependent manner

Abstract

The myosin-containing thick filament has recently been shown to alter its resting activation level in response to multiple diseases and therapeutics. Changes in thick filament resting activation level are caused by myosin heads transitioning between OFF and ON conformational states. Functionally, this modulation of thick filament activation level is a key regulatory step in muscle contraction and a promising therapeutic target. The availability of resting ON-state myosin heads governs dynamic contractility, which is critical to physical function and well-being. At present, there is a lack of compounds favouring this ON-state in resting skeletal muscle. Piperine is a molecule known to bind to myosin and increase submaximal isometric contractility in fast and slow skeletal muscle. Yet, effects on dynamic contractility and the underlying mechanism responsible for the observed effects in skeletal muscles remain unclear. Here, we used fibre small-angle X-ray diffraction and intact-muscle ex vivo contractility experiments to determine the effects of piperine on resting myosin structure and dynamic contractility in fast and slow rat muscles. X-ray diffraction data suggest that piperine promotes an OFF-to-ON transition of myosin in resting skeletal muscle, increasing the availability of myosin heads for force generation. Functionally, piperine substantially enhanced dynamic contractility in both muscle types, with greater improvements in slow muscle during maximal activation. These findings establish piperine as a tool to probe thick-filament activation in skeletal muscle, highlighting fibre-type-specific effects of thick-filament activation on the recruitment of the contractile reserve capacity. Key Points- Piperine is a compound known to bind to skeletal muscle myosin and enhance isometric contractility in fast and slow muscles, but the underlying molecular mechanisms and effects on dynamic contractile function remain unknown. - We show that piperine increases the activation level of the myosin-containing thick filament in resting fast and slow skeletal muscle, which may explain the effect of piperine on contractile function. - Piperine substantially increases the maximal contractile power of both fast and slow skeletal muscles at low-frequency activation; however, it only enhances the maximal power in slow skeletal muscle at high-frequency activation. - Our data reveal potentiation of dynamic contractility with fibre-type-dependent magnitudes in response to piperine-induced activation of the resting thick filament, a phenomenon that requires further investigation and may ultimately be exploited in the treatment of diseases characterised by muscle weakness. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/689918v2_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@1ff3672org.highwire.dtl.DTLVardef@4f809forg.highwire.dtl.DTLVardef@1857404org.highwire.dtl.DTLVardef@83d958_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical abstractC_FLOATNO Abstract figure legend: We investigated the effects of piperine on 1) the activation level of the resting thick filament and 2) dynamic contractility in fibres and intact slow (soleus) and fast (extensor digitorum longus, EDL) rat muscles, respectively. The activation level of the resting thick filament was assessed pre- and post-piperine incubation using small-angle X-ray diffraction. Dynamic contractility was assessed at submaximal and maximal activation levels by constructing low- and high-frequency force-velocity curves and corresponding power curves using an ex vivo contraction setup. The setup allows for simultaneous experiments on the effects of piperine and vehicle treatment in contralateral muscles. We found that piperine increased the activation level of the resting thick filament by favouring the ON-myosin state in fibres from both muscle types. In whole muscle preparations, piperine also induced substantial increases in dynamic contractility, especially in slow soleus muscle. C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kruse, D. Z., Herskind, J., Kuehn, M. N., Klotz, A. J., Hessel, A. L., Overgaard, K.. 2025-11-27. Piperine activates the thick filament of resting rat skeletal muscle, enhancing dynamic contractility in a fiber-type-dependent manner. https://doi.org/10.1101/2025.11.24.689918

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗